drugset / Trial / NCT00520585
Study of Influence of Atorvastatin on the Repolarisation Phase of Cardiomyocytes
Unknown
Masaryk University
Non-randomizedCrossoverDouble-blindBasic science
Summary
The aim of this study is to evaluate influence of atorvastin on the repolarisation phase of cardiomyocytes. If there is any, it could be a part of positive "non-lipid" effect of statins in therapy of ischaemic heart disease. Study hypothesis: atorvastin will decrease heterogeneity of repolarisation of cardiomyocytes in comparison with placebo
Timeline
- Start
- 2007-08
- Primary completion
- —
- Completion
- 2007-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 20 mg | — |
| Subject | Atorvastatin | Small molecule | 80 mg | — |
Indications
No indication recorded.